Tennis legend and ESPN analyst Chris Evert has confirmed that her ovarian cancer has returned, necessitating further medical treatment and her withdrawal from upcoming broadcasting duties at Wimbledon. Evert, an 18-time Grand Slam singles champion, first announced her diagnosis in January 2022 and had previously been declared cancer-free.
Why is Chris Evert stepping away from Wimbledon?
Chris Evert will not participate in the 2024 Wimbledon coverage due to a recurrence of ovarian cancer. According to an official statement released by the tennis icon, a recent PET/CT scan revealed the presence of cancer cells in the same pelvic region where she was originally treated. Evert noted that she underwent a successful robotic surgery to remove the malignant tissue. Following the procedure, she remains under the care of her oncology team and is currently undergoing follow-up treatment to ensure the cancer does not spread further.
Background on Evert’s cancer journey
Evert’s initial diagnosis in December 2021 followed a preventative hysterectomy. Genetic testing identified a BRCA1 mutation, which significantly increased her risk for ovarian and breast cancers. She shared her story publicly in January 2022 to raise awareness about the importance of genetic testing and early detection. After completing six rounds of chemotherapy, she was declared cancer-free in May 2022. The current recurrence marks the third time Evert has faced health complications related to this diagnosis, as she has remained transparent about the ongoing nature of her medical monitoring.
How medical experts view ovarian cancer recurrence
Ovarian cancer is frequently characterized by a high rate of recurrence, even after successful initial treatment. According to the American Cancer Society, the majority of women diagnosed with advanced-stage ovarian cancer will experience a return of the disease. Medical professionals typically treat recurrent cases with a combination of surgery, chemotherapy, and targeted therapies, such as PARP inhibitors, which are designed to prevent cancer cells from repairing their DNA. Evert’s proactive approach to regular screenings allowed her team to identify the recurrence at an early stage, which is a critical factor in managing the disease.
Impact on the tennis community
The sports world has rallied behind Evert, with ESPN expressing full support for her decision to prioritize her health over her professional obligations. As one of the most recognizable figures in tennis history, Evert’s advocacy has influenced how many fans and athletes approach their own preventative health screenings. Her absence from the broadcast booth at the All England Club leaves a significant void in the commentary team, but industry peers have emphasized that her recovery is the primary concern.
Key Facts Regarding the Diagnosis
- Diagnosis: Recurrence of ovarian cancer in the pelvic region.
- Treatment: Recent robotic surgery followed by ongoing oncology care.
- Broadcasting Status: Confirmed absence from 2024 Wimbledon coverage.
- Precedent: Evert carries the BRCA1 gene mutation, which informed her initial 2021 diagnosis.
Evert has indicated that she intends to return to her broadcasting role once her doctors clear her to resume work. For now, she continues to focus on her treatment, maintaining the same disciplined approach that defined her career on the court.